Edwards Lifesciences today shared new data demonstrating successful outcomes with its mitral and tricuspid therapies.

Chennai-based Prof. Dr Ajith Pillai, chief cardiologist & HOD at Kauvery Hospital, Radial Road, performed the minimally invasive MyClip procedure ...

Narratives from top Indian hospitals showcase medical breakthroughs, from complex heart surgeries and organ transplants to ...

The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc.

Edwards Lifesciences (NYSE: EW) today announced data demonstrating successful patient outcomes supporting its portfolio of mitral and tricuspid therapies. One-year data from the ENCIRCLE single-arm ...

These companies have already handsomely rewarded longtime shareholders, and it's not too late to join the party.

The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 /PRNewswire/ -- ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

More than 10 million older adults in the U.S. have mild or greater valvular heart disease and the prevalence is expected to grow over the next several decades, according to data from the PREVUE-VALVE ...

Doctors in Chennai have successfully treated a 58-year-old woman suffering from severe kidney disease (on dialysis), liver ...

Abbott, a global healthcare leader, signed a strategic partnership agreement with FPT Long Chau on October 30 to improve ...

Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in ...